Key NovaUCD Results
Key achievements made by NovaUCD during 2009 include:
- Seven new UCD spin-out companies incorporated
- Eighty-five invention disclosures reported
- Forty-seven patent applications filed across all areas of life sciences, engineering and information communication technology including
- 25 priority patent applications
- 17 PCT (Patent Co-operation Treaty) applications
- 5 national/regional patent applications - Fifteen licence agreements concluded with a range of indigenous and international companies
- Fifteen new ventures completed the NovaUCD 2009 Campus Company Development Programme
- BiancaMed successfully raised €6 million in second round funding
- UCD’s most successful licence to date, a BSE (Bovine Spongiform Encephalopathy) test, has now earned over €2 million in royalty income for UCD
- Several NovaUCD companies, including Duolog Technologies, Celtic Catalysts, Lightwave Technologies and Visor attracted investment
- The NovaUCD 2009 Innovation Award presented to Nicola Mitchell, founder Life Scientific and BioScientific Diagnostics
- Twenty-five knowledge-intensive ventures occupying 90% of the incubation space located at NovaUCD at year end
During 2009 NovaUCD continued its various initiatives to support researchers and entrepreneurs.
- NovaUCD arranged and hosted well over 100 events to increase awareness of intellectual property and other commercial issues and to promote a culture of entrepreneurship and innovation among researchers, students and staff
- Accredited PhD modules in innovation and knowledge transfer were delivered as part of UCD’s Graduate Studies’ Structured PhD Programme
- Increasing levels of support were provided by NovaUCD and its network for innovators and entrepreneurs in bringing their ideas from the research laboratory through proof-of-principle and prototype development to successful commercialisation.
Summary Key NovaUCD 2009 Metrics
- 7 new UCD spin-out incorporated
- 25 companies located at NovaUCD
- 85 invention disclosures
- 25 priority patent applications
- 17 PCT patent applications
- 5 national/regional patent applications
- 15 licence agreements
- 15 new ventures completed NovaUCD’s 2009 CCDP
Summary Key NovaUCD 2005-2009 Metrics
- ChangingWorlds acquired for $60 million
- Over €3 million generated from commercialisation of research
- 50 start-ups availed of NovaUCD’s incubation facilities
- 13 new UCD spin-outs incorporated
- 247 invention disclosures
- 88 priority patent applications
- 53 licence agreements.
For further information contact:
Micéal Whelan
Communications
t: + 353 1 716 3712
e: miceal.whelan@ucd.ie